Ocaliva 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQWPF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,736
Award facts
- Contract value 100% obligated
- $9,736.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for Ocaliva 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $9,736.39 with an ultimate completion date of September 17, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized medications and medical products to military health facilities. The company's extensive contract portfolio with the DLA reflects its role in distributing branded and generic prescription drugs, biologics, and medical consumables across various product categories. This delivery order for Ocaliva, a specialty pharmaceutical product, exemplifies the company's ongoing support of DoD healthcare logistics and its positioning as a key vendor for federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DB25FQWPF?
SPE2DB25FQWPF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FQWPF worth?
The government has obligated $9,736 on SPE2DB25FQWPF.
Is contract SPE2DB25FQWPF an order under another contract?
Yes. SPE2DB25FQWPF is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWPF competed?
The extent of competition for SPE2DB25FQWPF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award